Skip to main content
Erschienen in: Indian Journal of Gastroenterology 4/2018

29.08.2018 | Original Article

Prevalence of hepatitis E virus viremia and antibodies among healthy blood donors in India

verfasst von: Harshita Katiyar, Amit Goel, Atul Sonker, Vishwajeet Yadav, Sadul Sapun, Rajendra Chaudhary, Rakesh Aggarwal

Erschienen in: Indian Journal of Gastroenterology | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Hepatitis E virus (HEV) is transmitted primarily through contaminated water and food. Recently, HEV viremia in blood donors and transfusion-related transmission of HEV have been reported, leading to calls to screen donated blood for this virus. However, these data are from regions where genotype 3 HEV is predominant. In India, where human infections are caused only by genotype 1 HEV, the frequency of subclinical HEV viremia is unknown.

Methods

Minipools of sera prepared from three donor units each from our institution's  blood bank in Lucknow, India, were tested for HEV RNA using a sensitive amplification-based assay. A randomly selected subset was also tested for IgG anti-HEV antibodies using a commercial (Wantai) immunoassay.

Results

Sera from 1799 donors (median [range] age 30 [18–63] years; 1746 [97.0%] men) were collected (June–July 2016, 900; November–December 2016, 899). Of these, 17 (0.95%), 16 (0.90%), and 3 (0.17%) tested positive for HBsAg, anti-HCV, and anti-HIV antibodies, respectively. None of the donors tested positive for HEV RNA. Of 633 randomly selected donors (age 30 [18–63] years, 613 [96.8%] male) tested for IgG anti-HEV, 383 (60.5%) tested positive. Seropositivity rate increased with age, being 70/136 (52%), 177/299 (59%), 100/154 (65%), 30/34 (88%), and 6/10 (60%) in the 18–24, 25–34, 35–44, 45–54, and 55 years or older age groups, respectively.

Conclusions

In healthy blood donors from northern India, HEV viremia is infrequent though anti-HEV antibody prevalence is high. This suggests that asymptomatic HEV viremia may be less frequent in areas with genotype 1 predominance than those with genotype 3 predominance.
Literatur
1.
Zurück zum Zitat Goel A, Aggarwal R. Advances in hepatitis E - II: epidemiology, clinical manifestations, treatment and prevention. Expert Rev Gastroenterol Hepatol. 2016;10:1065–74.CrossRefPubMed Goel A, Aggarwal R. Advances in hepatitis E - II: epidemiology, clinical manifestations, treatment and prevention. Expert Rev Gastroenterol Hepatol. 2016;10:1065–74.CrossRefPubMed
2.
Zurück zum Zitat Lee GH, Tan BH, Teo EC, et al. Chronic infection with camelid hepatitis E virus in a liver transplant recipient who regularly consumes camel meat and milk. Gastroenterology. 2016;150:355–7. e3CrossRefPubMed Lee GH, Tan BH, Teo EC, et al. Chronic infection with camelid hepatitis E virus in a liver transplant recipient who regularly consumes camel meat and milk. Gastroenterology. 2016;150:355–7. e3CrossRefPubMed
3.
Zurück zum Zitat Donnelly MC, Scobie L, Crossan CL, Dalton H, Hayes PC, Simpson KJ. Review article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy. Aliment Pharmacol Ther. 2017;46:126–41.CrossRefPubMed Donnelly MC, Scobie L, Crossan CL, Dalton H, Hayes PC, Simpson KJ. Review article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy. Aliment Pharmacol Ther. 2017;46:126–41.CrossRefPubMed
5.
Zurück zum Zitat Naik SR, Aggarwal R, Salunke PN, Mehrotra NN. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organ 1992;70:597–604. Naik SR, Aggarwal R, Salunke PN, Mehrotra NN. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organ 1992;70:597–604.
6.
Zurück zum Zitat Dalton HR, Izopet J. Transmission and epidemiology of hepatitis E virus genotype 3 and 4 infections. Cold Spring Harbor Perspect Med. 2018. pii: a032144. Dalton HR, Izopet J. Transmission and epidemiology of hepatitis E virus genotype 3 and 4 infections. Cold Spring Harbor Perspect Med. 2018. pii: a032144.
7.
Zurück zum Zitat Kamar N, Izopet J, Pavio N, et al. Hepatitis E virus infection. Nat Rev Dis Primers. 2017;3:17086.CrossRefPubMed Kamar N, Izopet J, Pavio N, et al. Hepatitis E virus infection. Nat Rev Dis Primers. 2017;3:17086.CrossRefPubMed
8.
Zurück zum Zitat Hewitt PE, Ijaz S, Brailsford SR, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet. 2014;384:1766–73.CrossRef Hewitt PE, Ijaz S, Brailsford SR, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet. 2014;384:1766–73.CrossRef
10.
Zurück zum Zitat Petrik J, Lozano M, Seed CR, et al. Hepatitis E. Vox Sang. 2016;110:93–103. Petrik J, Lozano M, Seed CR, et al. Hepatitis E. Vox Sang. 2016;110:93–103.
11.
Zurück zum Zitat Pawlotsky JM. Hepatitis E screening for blood donations: an urgent need? Lancet. 2014;384:1729–30.CrossRef Pawlotsky JM. Hepatitis E screening for blood donations: an urgent need? Lancet. 2014;384:1729–30.CrossRef
12.
Zurück zum Zitat Domanovic D, Tedder R, Blumel J, et al. Hepatitis E and blood donation safety in selected European countries: a shift to screening? Euro Surveill. 2017;22:30514.CrossRefPubMedPubMedCentral Domanovic D, Tedder R, Blumel J, et al. Hepatitis E and blood donation safety in selected European countries: a shift to screening? Euro Surveill. 2017;22:30514.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Aggarwal R, Goel A. Screening transfusions for hepatitis E virus: is it needed in India? Natl Med J India. 2015;28:217–9.PubMed Aggarwal R, Goel A. Screening transfusions for hepatitis E virus: is it needed in India? Natl Med J India. 2015;28:217–9.PubMed
15.
Zurück zum Zitat Arankalle VA, Chobe LP. Hepatitis E virus: can it be transmitted parenterally? J Viral Hepat. 1999;6:161–4.CrossRefPubMed Arankalle VA, Chobe LP. Hepatitis E virus: can it be transmitted parenterally? J Viral Hepat. 1999;6:161–4.CrossRefPubMed
16.
Zurück zum Zitat Khuroo MS, Kamili S, Yattoo GN. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol. 2004;19:778–84.CrossRefPubMed Khuroo MS, Kamili S, Yattoo GN. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol. 2004;19:778–84.CrossRefPubMed
17.
Zurück zum Zitat Arankalle VA, Chobe LP. Retrospective analysis of blood transfusion recipients: evidence for post-transfusion hepatitis E. Vox Sang. 2000;79:72–4.CrossRefPubMed Arankalle VA, Chobe LP. Retrospective analysis of blood transfusion recipients: evidence for post-transfusion hepatitis E. Vox Sang. 2000;79:72–4.CrossRefPubMed
18.
Zurück zum Zitat Jothikumar N, Cromeans TL, Robertson BH, Meng XJ, Hill VR. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J Virol Methods. 2006;131:65–71.CrossRefPubMed Jothikumar N, Cromeans TL, Robertson BH, Meng XJ, Hill VR. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J Virol Methods. 2006;131:65–71.CrossRefPubMed
19.
Zurück zum Zitat Minagi T, Okamoto H, Ikegawa M, et al. Hepatitis E virus in donor plasma collected in Japan. Vox Sang. 2016;111:242–6.CrossRefPubMed Minagi T, Okamoto H, Ikegawa M, et al. Hepatitis E virus in donor plasma collected in Japan. Vox Sang. 2016;111:242–6.CrossRefPubMed
20.
Zurück zum Zitat Baylis SA, Gartner T, Nick S, Ovemyr J, Blumel J. Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang. 2012;103:89–90.CrossRefPubMed Baylis SA, Gartner T, Nick S, Ovemyr J, Blumel J. Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang. 2012;103:89–90.CrossRefPubMed
21.
Zurück zum Zitat Arankalle VA, Tsarev SA, Chadha MS, et al. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J Infect Dis. 1995;171:447–50.CrossRefPubMed Arankalle VA, Tsarev SA, Chadha MS, et al. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J Infect Dis. 1995;171:447–50.CrossRefPubMed
22.
Zurück zum Zitat Gupta BP, Lama TK, Adhikari A, et al. First report of hepatitis E virus viremia in healthy blood donors from Nepal. Virusdisease. 2016;27:324–6.CrossRefPubMedPubMedCentral Gupta BP, Lama TK, Adhikari A, et al. First report of hepatitis E virus viremia in healthy blood donors from Nepal. Virusdisease. 2016;27:324–6.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Gupta N, Sarangi AN, Dadhich S, et al. Acute hepatitis E in India appears to be caused exclusively by genotype 1 hepatitis E virus. Indian J Gastroenterol. 2018;37:44–9.CrossRefPubMed Gupta N, Sarangi AN, Dadhich S, et al. Acute hepatitis E in India appears to be caused exclusively by genotype 1 hepatitis E virus. Indian J Gastroenterol. 2018;37:44–9.CrossRefPubMed
24.
Zurück zum Zitat Singh A, Seth R, Gupta A, et al. Chronic hepatitis E - an emerging disease in an immunocompromised host. Gastroenterol Rep (Oxf). 2016. pii: gow024. Singh A, Seth R, Gupta A, et al. Chronic hepatitis E - an emerging disease in an immunocompromised host. Gastroenterol Rep (Oxf). 2016. pii: gow024.
25.
Zurück zum Zitat Naik A, Gupta N, Goel D, Ippagunta SK, Sharma RK, Aggarwal R. Lack of evidence of hepatitis E virus infection among renal transplant recipients in a disease-endemic area. J Viral Hepat. 2013;20:e138–40.CrossRefPubMed Naik A, Gupta N, Goel D, Ippagunta SK, Sharma RK, Aggarwal R. Lack of evidence of hepatitis E virus infection among renal transplant recipients in a disease-endemic area. J Viral Hepat. 2013;20:e138–40.CrossRefPubMed
26.
Zurück zum Zitat Munjal S, Gupta N, Sharma RK, et al. Lack of persistent hepatitis E virus infection as a cause for unexplained transaminase elevation in renal transplant recipients in India. Indian J Gastroenterol. 2014;33:550–3.CrossRefPubMed Munjal S, Gupta N, Sharma RK, et al. Lack of persistent hepatitis E virus infection as a cause for unexplained transaminase elevation in renal transplant recipients in India. Indian J Gastroenterol. 2014;33:550–3.CrossRefPubMed
27.
Zurück zum Zitat Agarwala P, Gupta E, Choudhary MC, Pamecha V. Absence of chronic hepatitis E virus infection in liver transplant recipients: report from a hyperendemic region. Indian J Gastroenterol. 2018;37:160–3.CrossRefPubMed Agarwala P, Gupta E, Choudhary MC, Pamecha V. Absence of chronic hepatitis E virus infection in liver transplant recipients: report from a hyperendemic region. Indian J Gastroenterol. 2018;37:160–3.CrossRefPubMed
28.
Zurück zum Zitat Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol. 2010;82:799–805.CrossRefPubMed Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol. 2010;82:799–805.CrossRefPubMed
29.
Zurück zum Zitat Zhang J, Zhang XF, Huang SJ, et al. Long-term efficacy of a hepatitis E vaccine. N Engl J Med. 2015;372:914–22. Zhang J, Zhang XF, Huang SJ, et al. Long-term efficacy of a hepatitis E vaccine. N Engl J Med. 2015;372:914–22.
Metadaten
Titel
Prevalence of hepatitis E virus viremia and antibodies among healthy blood donors in India
verfasst von
Harshita Katiyar
Amit Goel
Atul Sonker
Vishwajeet Yadav
Sadul Sapun
Rajendra Chaudhary
Rakesh Aggarwal
Publikationsdatum
29.08.2018
Verlag
Springer India
Erschienen in
Indian Journal of Gastroenterology / Ausgabe 4/2018
Print ISSN: 0254-8860
Elektronische ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-018-0880-7

Weitere Artikel der Ausgabe 4/2018

Indian Journal of Gastroenterology 4/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.